424 results on '"Aydinok, Yesim"'
Search Results
2. Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study
3. The effect of virtual reality on pain, fear, and anxiety during access of a port with huber needle in pediatric hematology-oncology patients: Randomized controlled trial
4. Identification of the molecular etiology in rare congenital hemolytic anemias using next‐generation sequencing with exome‐based copy number variant analysis
5. Iron Chelation Therapy as a Modality of Management
6. Correction to: Modern management of iron overload in thalassemia major patients guided by MRI techniques: real‑world data from a long‑term cohort study
7. Randomized controlled trial of care bundles with chlorhexidine dressing and advanced dressings to prevent catheter-related bloodstream infections in pediatric hematology-oncology patients
8. Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia
9. Combination chelation therapy
10. Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years
11. Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study
12. Systematic literature review of the indirect costs and humanistic burden of β-thalassemia.
13. Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
14. Highlights on the Luspatercept Treatment in Thalassemia
15. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)
16. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion‐dependent thalassaemia
17. Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia
18. Action plan to regain unnecessary deferred blood donors due to malaria risk in Turkey
19. A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload
20. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
21. An open‐label, multicenter, efficacy and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results
22. Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study (Jan, 10.1007/s00277-021-04748-w, 2022) [Correction]
23. Hematuria in Patients with Congenital Coagulation Factor Deficiencies
24. Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia
25. Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study
26. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005–2013
27. Systematic Literature Review of the Indirect Costs, Humanistic Burden, Patient or Caregiver Preference, and Qualitative Outcomes in Beta-Thalassemia
28. A Phase 2a Study Evaluating the Safety and Pharmacokinetics (PK) of Luspatercept in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT)
29. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine
30. Current approach to iron chelation in children
31. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)
32. Worldwide survey of T2* cardiovascular magnetic resonance in Thalassaemia
33. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
34. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload
35. The Effect of Reducing Repetition Time TR on the Measurement of Liver R2 for the Purpose of Measuring Liver Iron Concentration
36. Evaluation of Liver Iron Content by Magnetic Resonance Imaging in Children with Acute Lymphoblastic Leukemia after Cessation of Treatment
37. Is Normal Growth and Development Achieved By Current Management Approaches to Thalassemia Major in the New Era?
38. Changing patterns in the epidemiology of β‐thalassemia
39. Evaluation of the achievement of hematologists to transfusion medicine education with self-assessment questionnaire in Turkey
40. Recommendations for Pregnancy in Rare Inherited Anemias
41. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
42. Whole-genome sequencing of a sporadic primary immunodeficiency cohort
43. Changing patterns in the epidemiology of beta-thalassemia
44. Myelofibrosis in a Child With EBV-Associated Hemophagocytic Lymphohistiocytosis
45. A further Turkish case of Griscelli syndrome with new RAB27A mutation
46. Menorrhagia due to abnormalities of the platelet function: Evaluation of two young patients
47. Tramadol infusion for the pain management in sickle cell disease: a case report
48. Evaluation of QT Dispersion in β Thalassaemia Major Patients
49. Psychosocial implications of Thalassemia Major
50. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.